Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02

Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med (1982) 4.20

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis (2009) 2.68

Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res (2011) 2.59

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med (1972) 2.20

Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med (2003) 2.09

Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med (2006) 1.68

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine (2006) 1.65

Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64

Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis (2008) 1.57

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis (2010) 1.53

Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant (1994) 1.42

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res (2005) 1.32

Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol (2008) 1.22

Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis (2009) 1.22

Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer (2005) 1.17

Influenza in children with cancer. J Pediatr (1989) 1.14

Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann Intern Med (2013) 1.14

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine (2011) 1.10

The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J (2001) 1.08

Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer (1999) 1.08

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients. J Neurosurg (1977) 1.03

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. J Infect Dis (2009) 1.03

Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. Ann Oncol (2011) 0.97

Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol (2000) 0.96

Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS (2013) 0.95

Common community respiratory viruses in patients with cancer: more than just "common colds". Cancer (2003) 0.93

Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer. Oncologist (2012) 0.90

Cost-effectiveness of influenza vaccination in working-age cancer patients. Cancer (2007) 0.90

An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. Nephrol Dial Transplant (2010) 0.83

Cocooning: a concept to protect young children from infectious diseases. Curr Opin Pediatr (2012) 0.82

The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies. Leuk Lymphoma (2011) 0.82

A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients. Oncologist (2012) 0.81

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes. J Neurooncol (1990) 0.81

Immunobiology of malignant gliomas. J Clin Neurosci (1996) 0.78

The immunobiology of malignant gliomas. Funct Neurol (2005) 0.77